Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Offin

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2019
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation BurdenRyma Benayed, Michael Offin, Kerry Mullaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2022
Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient SubsetChristopher A Febres-Aldana, Jason C Chang, Ryan Ptashkin, et al.
JTO Clinical and Research Reports|April 6, 2026
Brain Metastases in Diffuse Pleural Mesothelioma: Clinical, Histologic, and Molecular CorrelatesAntonio Ocejo, Clare Wilhem, Francis M Bodd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i>-Mutant Lung CancerAdam J Schoenfeld, Joseph M Chan, Daisuke Kubota, et al.
The Journal of Molecular Diagnostics : JMD|May 17, 2025
Leveraging RNA from DNA Extraction Lysate to Rescue "Insufficient" Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor SpecimensMark D Ewalt, Sara E DiNapoli, Kerry Mullaney, et al.
Nature Medicine|October 19, 2025
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trialTimothy A Yap, David J Kwiatkowski, Ibiayi Dagogo-Jack, et al.
JTO Clinical and Research Reports|September 30, 2021
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLCAnnemarie F Shepherd, Anthony F Yu, Michelle Iocolano, et al.
Genome Medicine|November 16, 2022
Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft libraryMichael Offin, Jennifer L Sauter, Sam E Tischfield, et al.
JCO Precision Oncology|June 14, 2019
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung CancersMichael Offin, Robin Guo, Stephanie L Wu, et al.
JAMA Network Open|March 10, 2023
Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal MesotheliomaMelina E Marmarelis, Xiao Wang, Leonid Roshkovan, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2019
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation BurdenRyma Benayed, Michael Offin, Kerry Mullaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2022
Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient SubsetChristopher A Febres-Aldana, Jason C Chang, Ryan Ptashkin, et al.
JTO Clinical and Research Reports|April 6, 2026
Brain Metastases in Diffuse Pleural Mesothelioma: Clinical, Histologic, and Molecular CorrelatesAntonio Ocejo, Clare Wilhem, Francis M Bodd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i>-Mutant Lung CancerAdam J Schoenfeld, Joseph M Chan, Daisuke Kubota, et al.
The Journal of Molecular Diagnostics : JMD|May 17, 2025
Leveraging RNA from DNA Extraction Lysate to Rescue "Insufficient" Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor SpecimensMark D Ewalt, Sara E DiNapoli, Kerry Mullaney, et al.
Nature Medicine|October 19, 2025
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trialTimothy A Yap, David J Kwiatkowski, Ibiayi Dagogo-Jack, et al.
JTO Clinical and Research Reports|September 30, 2021
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLCAnnemarie F Shepherd, Anthony F Yu, Michelle Iocolano, et al.
Genome Medicine|November 16, 2022
Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft libraryMichael Offin, Jennifer L Sauter, Sam E Tischfield, et al.
JCO Precision Oncology|June 14, 2019
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung CancersMichael Offin, Robin Guo, Stephanie L Wu, et al.
JAMA Network Open|March 10, 2023
Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal MesotheliomaMelina E Marmarelis, Xiao Wang, Leonid Roshkovan, et al.
Pageof 9